147 related articles for article (PubMed ID: 21075162)
1. High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women.
Magistrado PA; Minja D; Doritchamou J; Ndam NT; John D; Schmiegelow C; Massougbodji A; Dahlbäck M; Ditlev SB; Pinto VV; Resende M; Lusingu J; Theander TG; Salanti A; Nielsen MA
Vaccine; 2011 Jan; 29(3):437-43. PubMed ID: 21075162
[TBL] [Abstract][Full Text] [Related]
2. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
[TBL] [Abstract][Full Text] [Related]
3. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
[TBL] [Abstract][Full Text] [Related]
4. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies.
Bordbar B; Tuikue-Ndam N; Bigey P; Doritchamou J; Scherman D; Deloron P
Vaccine; 2012 Feb; 30(7):1343-8. PubMed ID: 22226864
[TBL] [Abstract][Full Text] [Related]
5. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
6. Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA.
Doritchamou J; Bigey P; Nielsen MA; Gnidehou S; Ezinmegnon S; Burgain A; Massougbodji A; Deloron P; Salanti A; Ndam NT
Vaccine; 2013 Sep; 31(41):4516-22. PubMed ID: 23933341
[TBL] [Abstract][Full Text] [Related]
7. Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates.
Khattab A; Reinhardt C; Staalsoe T; Fievet N; Kremsner PG; Deloron P; Hviid L; Klinkert MQ
Malar J; 2004 Jul; 3():21. PubMed ID: 15242514
[TBL] [Abstract][Full Text] [Related]
8. The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
Pinto VV; Salanti A; Joergensen LM; Dahlbäck M; Resende M; Ditlev SB; Agger EM; Arnot DE; Theander TG; Nielsen MA
Vaccine; 2012 Jan; 30(3):572-9. PubMed ID: 22122859
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women.
Tuikue Ndam NG; Salanti A; Le-Hesran JY; Cottrell G; Fievet N; Turner L; Sow S; Dangou JM; Theander T; Deloron P
J Infect Dis; 2006 Mar; 193(5):713-20. PubMed ID: 16453268
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.
Fievet N; Le Hesran JY; Cottrell G; Doucoure S; Diouf I; Ndiaye JL; Bertin G; Gaye O; Sow S; Deloron P
Infect Genet Evol; 2006 Nov; 6(6):459-63. PubMed ID: 16621725
[TBL] [Abstract][Full Text] [Related]
12. Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia.
Staalsoe T; Megnekou R; Fievét N; Ricke CH; Zornig HD; Leke R; Taylor DW; Deloron P; Hviid L
J Infect Dis; 2001 Sep; 184(5):618-26. PubMed ID: 11494167
[TBL] [Abstract][Full Text] [Related]
13. Functional and immunological characterization of the var2CSA-DBL5epsilon domain of a placental Plasmodium falciparum isolate.
Gangnard S; Tuikue Ndam NG; Gnidehou S; Quiviger M; Juillerat A; Faure G; Baron B; Viwami F; Deloron P; Bentley GA
Mol Biochem Parasitol; 2010 Oct; 173(2):115-22. PubMed ID: 20562018
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin.
Nielsen MA; Resende M; Alifrangis M; Turner L; Hviid L; Theander TG; Salanti A
Exp Parasitol; 2007 Sep; 117(1):1-8. PubMed ID: 17442305
[TBL] [Abstract][Full Text] [Related]
15. Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin.
Rasti N; Namusoke F; Chêne A; Chen Q; Staalsoe T; Klinkert MQ; Mirembe F; Kironde F; Wahlgren M
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13795-800. PubMed ID: 16945914
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.
Barfod L; Dobrilovic T; Magistrado P; Khunrae P; Viwami F; Bruun J; Dahlbäck M; Bernasconi NL; Fried M; John D; Duffy PE; Salanti A; Lanzavecchia A; Lim CT; Ndam NT; Higgins MK; Hviid L
J Immunol; 2010 Dec; 185(12):7553-61. PubMed ID: 21078904
[TBL] [Abstract][Full Text] [Related]
17. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
[TBL] [Abstract][Full Text] [Related]
18. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
[TBL] [Abstract][Full Text] [Related]
19. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
[TBL] [Abstract][Full Text] [Related]
20. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.
Staalsoe T; Shulman CE; Bulmer JN; Kawuondo K; Marsh K; Hviid L
Lancet; 2004 Jan; 363(9405):283-9. PubMed ID: 14751701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
